Hóvihar járulékos utánzó ugt1a1 wiki Nukleáris Integráció indica
RCSB PDB - 7VVH: Crystal Structure of the Kv7.1 C-terminal Domain in Complex with Calmodulin disease mutation E140G
Cost–effectiveness analysis of UGT1A1*6/*28 genotyping for preventing FOLFIRI-induced severe neutropenia in Chinese colorectal cancer patients | Pharmacogenomics
The Effect of UGT1A1 Promoter Polymorphism in the Development of Hyperbilirubinemia and Cholelithiasis in Hemoglobinopathy Patients | PLOS ONE
Frontiers | UGT1A1 Variants c.864+5G>T and c.996+2_996+5del of a Crigler-Najjar Patient Induce Aberrant Splicing in Minigene Assays
File:PDB 2ig7 EBI.png - Wikimedia Commons
UGT1A1 Gene - GeneCards | UD11 Protein | UD11 Antibody
File:PDB 4pgt EBI.jpg - Wikimedia Commons
UGT1A10 Gene - GeneCards | UD110 Protein | UD110 Antibody
Glucuronidation by UGT1A1 Is the Dominant Pathway of the Metabolic Disposition of Belinostat in Liver Cancer Patients | PLOS ONE
UGT1A1 Gene - GeneCards | UD11 Protein | UD11 Antibody
UGT1A10 Gene - GeneCards | UD110 Protein | UD110 Antibody
Association between UGT1A1*28 Polymorphisms and Clinical Outcomes of Irinotecan-Based Chemotherapies in Colorectal Cancer: A Meta-Analysis in Caucasians | PLOS ONE
Glucuronosyltransferase - Wikipedia
Association of UGT1A1 Variants and Hyperbilirubinemia in Breast-Fed Full-Term Chinese Infants | PLOS ONE
UGT1A10 Gene - GeneCards | UD110 Protein | UD110 Antibody
AOP-Wiki
AOP-Wiki
File:PDB 2ake EBI.jpg - Wikimedia Commons
UGT1A10 Gene - GeneCards | UD110 Protein | UD110 Antibody
Association of UGT1A1 Variants and Hyperbilirubinemia in Breast-Fed Full-Term Chinese Infants | PLOS ONE
A UGT1A1 variant is associated with serum total bilirubin levels, which are causal for hypertension in African-ancestry individuals | npj Genomic Medicine
UGT1A1 polymorphisms in cancer: impact on irinotecan treatment. - Abstract - Europe PMC
UGT1A1 Gene - GeneCards | UD11 Protein | UD11 Antibody
Molecules | Free Full-Text | Strong Inhibition of Celastrol Towards UDP-Glucuronosyl Transferase (UGT) 1A6 and 2B7 Indicating Potential Risk of UGT-Based Herb-Drug Interaction